文献速递临床试验与 GCP

机器人辅助治疗对脑卒中患者上肢和认知功能的影响:随机对照研究的研究方案

Effects of robot-assisted therapy on upper limb and cognitive function in patients with stroke: study protocol of a randomized controlled study.
PubMed 文献 · Trials · 2022-06-28

这是一项单盲、双臂平行随机对照试验方案,计划在中国上海一家临床医院招募86例急性期和亚急性期脑卒中患者,随机接受机器人辅助治疗或常规治疗,干预6周。主要结局为上肢Fugl-Meyer评估(FMA-UE)和简易精神状态检查(MMSE),所有结局在基线和6周随访时评估,并进行意向性治疗分析。

要点

  • 计划招募86例急性期和亚急性期脑卒中患者,随机分为机器人辅助治疗组和常规治疗组。
  • 机器人辅助治疗组在综合康复基础上接受Armguider机器人辅助治疗,每次30分钟,每周5天,持续6周。
  • 主要结局为FMA-UE和MMSE,次要结局包括TMT、AVLT、DSST和ROCFT,基线和6周随访时评估。

核心结论

  • 该研究将是首个旨在探讨机器人辅助治疗对急性期和亚急性期脑卒中患者上肢和认知功能影响的随机对照试验。
  • 研究结果将有助于理解新型机器人康复方法在脑卒中护理和康复中的应用。

研究设计与样本

  • 单盲、双臂平行设计随机对照试验,计划样本量为86例急性期和亚急性期脑卒中患者。
  • 患者将从中国上海一家临床医院招募,随机分配接受机器人辅助治疗或常规治疗。
  • 两组干预均在临床康复环境中进行,持续6周。
  • 机器人辅助治疗组在综合康复基础上接受Armguider机器人辅助治疗,每次30分钟,每周5天。
  • 所有结局在基线和6周随访时评估,采用意向性治疗分析检验结局较基线的变化,并全程监测不良事件。

关键数值与推荐

  • 主要疗效结局包括上肢Fugl-Meyer评估(FMA-UE)和简易精神状态检查(MMSE)。
  • 次要结局包括连线测验(TMT)、听觉词语学习测验(AVLT)、数字符号替换测验(DSST)和Rey-Osterrieth复杂图形测验(ROCFT)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impairments in upper limb motor function and cognitive ability are major health problems experienced by stroke patients, necessitating the development of novel and effective treatment options in stroke care. The aim of this study is to examine the effects of robot-assisted therapy on improving upper limb and cognitive functions in stroke patients. METHODS: This will be a single-blinded, 2-arm, parallel design, randomized controlled trial which will include a sample size of 86 acute and subacute stroke patients to be recruited from a single clinical hospital in Shanghai, China. Upon qualifying the study eligibility, participants will be randomly assigned to receive either robot-assisted therapy or conventional therapy with both interventions being conducted over a 6-week period in a clinical rehabilitation setting. In addition to comprehensive rehabilitation, the robot-assisted therapy group will receive a 30-min Armguider robot-assisted therapy intervention 5 days a week. Primary efficacy outcomes will include Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and Mini-Mental Status Examination (MMSE). Other secondary outcomes will include Trail Making Test (TMT), Auditory Verbal Learning Test (AVLT), Digit Symbol Substitution Test (DSST), and Rey-Osterrieth Complex Figure Test (ROCFT). All trial outcomes will be assessed at baseline and at 6-week follow-up. Intention-to-treat analyses will be performed to examine changes from baseline in the outcomes. Adverse events will be monitored throughout the trial period. DISCUSSION: This will be the first randomized controlled trial aimed at examining the effects of robot-assisted therapy on upper limb and cognitive functions in acute and subacute stroke patients. Findings from the study will contribute to our understanding of using a novel robotic rehabilitation approach to stroke care and rehabilitation. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100050856 . Registered on 5 September 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang Y, Ye M, Tong Y, et al. Effects of robot-assisted therapy on upper limb and cognitive function in patients with stroke: study protocol of a randomized controlled study. Trials. 2022. PMID: 35765084. doi:10.1186/s13063-022-06361-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。